Institutes
July 21, 2020
UAMS Winthrop P. Rockefeller Cancer Institute Expands Services with Addition of 12 Oncologists
LITTLE ROCK — The addition of 12 oncologists will expand services and increase access for patients at the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS). “We are in a period of significant growth at the Winthrop P. Rockefeller Cancer Institute and are proud to welcome 12 talented physicians…
July 20, 2020
Special Lenses Help Former Gallery Owner See Color Again
When Frances Sego, of Fayetteville, puts in the special contact lenses she got through seeking care at the UAMS Harvey & Bernice Jones Eye Institute, “it’s like putting a new lightbulb in your eye each morning.” Plagued by complications resulting from corneal dystrophy, which causes irregularities to the clear outer layer of the eye, her…
July 16, 2020
UAMS, Arkansas Children’s, Baptist Health and Proton International Sign Letter of Intent to Build State’s First Proton Treatment Center
LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS), Arkansas Children’s, Baptist Health and Proton International (PI) have signed a Letter of Intent to bring proton therapy — an alternative to radiation therapy for treating cancer — to Arkansas.
July 8, 2020
Little Rock Firefighter Survives COVID-19, Donates Plasma
It was still early days in the sweep of COVID-19 across the country when John Fulbright of Cabot, a paramedic and firefighter in Little Rock, found himself admitted to UAMS with shortness of breath and fever. “After I was hospitalized, it got worse before it got better. I was little concerned about being put on…
July 1, 2020
UAMS First in Arkansas to Use ExcelsiusGPS for Robot-Assisted Spinal Surgery
UAMS Medical Center is the first hospital in Arkansas to operate with the ExcelsiusGPS robotic spine navigation system that helps improve accuracy and reduce the invasiveness of spinal surgery. Both the Department of Orthopaedic Surgery and Department of Neurosurgery use the new spine robot for patients needing spine surgery. Noojan Kazemi, M.D., an associate professor…
UAMS Winthrop P. Rockefeller Cancer Institute Elects New Board of Advisors Members
The Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS) announces the election of new members to its Board of Advisors.
June 26, 2020
George and Linda Gleason Foundation Gives $100,000 for UAMS Psychiatric Research Institute, Department of Neurology
The George and Linda Gleason Foundation has given $100,000 to the University of Arkansas for Medical Sciences (UAMS), split evenly among the Department of Neurology in the College of Medicine and the Psychiatric Research Institute. The Gleasons were on hand Friday, June 19 to present a check to R. Lee Archer, M.D., chair of the…
June 25, 2020
Digital Health Visits Help Regional Campuses Meet COVID-19 Challenges
Brittnay Hall, 39, was at an impasse: COVID-19 worries were making worse her pre-existing problems with anxiety. Also, thinking of having an in-person visit with her physician about her anxiety medications made her feel unsafe. Digital health technology resolved her dilemma. Hall, of Newark, had a more-than-20-year patient-physician relationship with Julia Roulier, M.D., a family…
UAMS-Developed High-Accuracy COVID-19 Antibody Testing Begins in Arkansas
LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) has developed and begun using high-accuracy antibody testing to determine the magnitude of COVID-19 infection in Arkansas and inform the decisions of policymakers. As part of the research program, UAMS will collect blood samples from nearly 7,500 Arkansas adults and children through October. By…
UAMS Cancer Institute Joins KIYATEC Clinical Study of Test to Predict Pre-Treatment, Patient-Specific Response to Ovarian Cancer Drugs
KIYATEC, Inc. today announced that the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS) has joined the growing roster of institutions participating in its 3D-PREDICT clinical study to validate the company’s test as a patient-specific predictor of response to recommended drug therapies for patients with ovarian cancer.
Previous page Next page